SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 80 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2014. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $2,590,000 | +77.0% | 470,000 | +22.1% | 2.45% | +74.4% |
Q2 2016 | $1,463,000 | +32.5% | 385,000 | -3.8% | 1.40% | +25.1% |
Q1 2016 | $1,104,000 | +36.6% | 400,000 | +180.7% | 1.12% | +7.3% |
Q4 2015 | $808,000 | +103.5% | 142,500 | +90.0% | 1.05% | +55.3% |
Q3 2015 | $397,000 | +32.3% | 75,000 | +107.2% | 0.67% | +102.4% |
Q2 2015 | $300,000 | +29.9% | 36,200 | -27.6% | 0.33% | +41.7% |
Q1 2015 | $231,000 | +312.5% | 50,000 | +150.0% | 0.24% | +434.1% |
Q3 2014 | $56,000 | -93.9% | 20,000 | -91.1% | 0.04% | -93.3% |
Q2 2014 | $915,000 | -31.0% | 225,000 | -10.0% | 0.66% | -40.8% |
Q1 2014 | $1,327,000 | -5.7% | 250,000 | 0.0% | 1.12% | -1.8% |
Q4 2013 | $1,407,000 | – | 250,000 | – | 1.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 2,200,000 | $6,072,000 | 2.38% |
GREAT POINT PARTNERS LLC | 2,175,000 | $6,003,000 | 2.15% |
Belmont Global Advisors, Inc. | 400,000 | $1,104,000 | 1.12% |
Trellus Management Company, LLC | 162,900 | $450,000 | 0.78% |
PURA VIDA INVESTMENTS, LLC | 572,800 | $1,581,000 | 0.72% |
DAFNA Capital Management LLC | 294,563 | $813,000 | 0.70% |
Twin Securities, Inc. | 1,687,115 | $4,656,000 | 0.58% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 1,000,000 | $2,760,000 | 0.33% |
WALL STREET ASSOCIATES | 269,300 | $743,000 | 0.31% |
Paulson & Co. | 11,090,000 | $30,608,000 | 0.23% |